NASDAQ:XNPT (XNPT) (XNPT) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free XNPT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$7.07▼$7.0750-Day Range N/A52-Week Range$3.35▼$7.86VolumeN/AAverage Volume1.22 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Ad Huge Alerts**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report About (XNPT) Stock (NASDAQ:XNPT)XenoPort, Inc. is a biopharmaceutical company. The Company is focused on commercializing HORIZANT (gabapentin enacarbil) Extended-Release Tablets in the United States. The Company's segment is the development and commercialization of product candidates for the treatment of neurological and other disorders. Its development-stage product candidates include XP23829, XP21279 and arbaclofen placarbil. HORIZANT has been approved by the United States Food and Drug Administration for the treatment of moderate-to-severe primary restless legs syndrome in adults and for the management of postherpetic neuralgia in adults. XP23829 is a fumaric acid ester compound and a prodrug of metabolite monomethyl fumarate being developed for the treatment for patients with moderate-to-severe chronic plaque-type psoriasis and/or patients with relapsing forms of multiple sclerosis. XP21279 is a Transported Prodrug of levodopa being developed for the treatment for patients with idiopathic Parkinson's disease.Read More Ad Huge Alerts**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report XNPT Stock News HeadlinesMay 13, 2023 | thestreet.com3 Biotech Stocks Under $10 Spiking HigherMay 6, 2023 | msn.comHowdy Neighbors just wanted to reach out to the Community and see if anyone else is having trouble getting people to actually show up and do the Bids or the work they promised.March 30, 2023 | bbc.comSiddingtonMarch 12, 2023 | msn.comMarch Madness: Alabama, Houston, Kansas, Purdue the 1 seedsFebruary 26, 2023 | msn.comLeicester star named ‘perfect’ Tottenham signing as they ‘need’ a player ‘like him’February 26, 2023 | msn.comPicard and Riker Just Reinstated Star Trek's 'Space Cowboy' TropeJanuary 31, 2023 | msn.comNumerology Number 4 Predictions Today, February 1, 2023: Health will be better!November 10, 2022 | msn.comOn birthday, Pakatan’s Bentong hopeful Rara says suffered miscarriageOctober 30, 2022 | msn.comImmigration minister visits Kent migrant facility amid growing safety concernsOctober 14, 2022 | msn.comBanned Aberdeen boss Jim Goodwin free to face Hearts and Rangers after submitting appealJuly 29, 2022 | thetimes.co.ukSan Francisco declares state of emergency over monkeypoxJuly 29, 2022 | thetimes.co.ukSan Francisco declares state of emergency over Monkeypox outbreakMay 26, 2022 | thestreet.comFive Dumbest Things on Wall Street: Feb. 26September 10, 2021 | news.yahoo.comHe swallowed the evidence, then as FBI went to arrest him in case of illicit images of a child, Caroline County judge killed himselfSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryPharmaceuticals Current SymbolNASDAQ:XNPT CUSIP98411C10 CIK1130591 Webwww.xenoport.com Phone+1-408-6167200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A XNPT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (XNPT) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (XNPT) investors own include Netflix (NFLX), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), Ionis Pharmaceuticals (IONS), Supernus Pharmaceuticals (SUPN), XOMA (XOMA), Allergan (AGN), Bausch Health Companies (BHC), Booking (BKNG) and This page (NASDAQ:XNPT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company Former CIA advisor: Dark side of AI now startingParadigm Press Adding Choose a watchlist: Watchlist My Default Watchlist Adding (XNPT) You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
